Table 1 Patients with SARS-CoV-2 associated polyradiculitis as reported by the end of December 2020
Age (years) | Sex | Onset | LOO (days) | Subtype | CIC | CM | IVIG | AV | Recovery | Country |
|---|---|---|---|---|---|---|---|---|---|---|
61 | f | B | 9 | AIDP | nr | No | Yes | No | Yes | China |
65 | m | A | 9 | AMSAN | nd | DM | Yes | No | nr | Iran |
54 | m | A | 8 | AIDP | nr | No | Yes | Yes | Yes | USA |
70 | f | A | 23 | AIDP | nd | No | Yes | Yes | nr | Italy |
66 | f | A | 7 | AIDP | No | nr | Yes | Yes | Yes | Italy |
54 | f | A | 21 | AIDP | nd | No | Yes | No | Yes | Germany |
70 | f | A | 3 | AMSAN | No | RA | Yes | No | Partial | Morocco |
20 | m | A | 5 | AMAN | nd | No | Yes | No | Yes | India |
71 | m | A | 4 | AIDP | No | AHT, AAR, LC | Yes | Yes | Death | Italy |
64 | m | A | 11 | AIDP | nd | No | Yes | Yes | nr | France |
nr | nr | A | 7 | AIDP | No | nr | Yes | No | Partial | Italy |
nr | nr | A | 10 | AIDP | No | nr | Yes | No | Yes | Italy |
nr | nr | A | 10 | AMAN | No | nr | Yes | Yes | Partial | Italy |
nr | nr | A | 5 | AMAN | No | nr | Yes | No | Partial | Italy |
nr | nr | A | 7 | AMAN | No | nr | Yes, PE | No | nr | Italy |
50 | m | A | 3 | MFS, PNC | No | No | Yes | No | Yes | Spain |
39 | m | A | 3 | MFS, PNC | No | No | No | No | Yes | Spain |
61 | m | A | 10 | MFS | No | No | S | No | Yes | Spain |
76 | f | A | 8 | GBS (no NCS) | nd | No | No | nr | Death | Spain |
~ 75 | m | B | 10 | AIDP | No | No | Yes | No | Yes | Swiss |
43 | m | A | 10 | AIDP | nr | nr | Yes | No | Yes | Spain |
64 | m | A | 23 | AIDP | No | nr | Yes | No | Yes | France |
72 | m | A | 7 | AIDP | No | AHT, CHD, AL | Yes | Yes | Partial | USA |
~ 65 | m | A | 17 | AIDP | No | No | Yes | No | Yes | Italy |
67 | f | A | 10 | nr | No | Breast cancer | PE | Yes | Partial | USA |
54 | m | A | 14 | AIDP | nd | nr | Yes | No | Partial | USA |
43 | m | A | 21 | AIDP | No | nr | Yes | No | Yes | France |
71 | f | A | 10 | AIDP | No | nr | Yes | No | Partial | France |
36 | m | A | 4 | MFS | nr | nr | Yes | No | Yes | USA |
55 | m | A | 20 | AIDP | No | nr | Yes | Yes | Partial | Italy |
60 | m | A | 3 | AMSAN | No | nr | Yes | Yes | Partial | Italy |
58 | m | AB | 0 | AIDP | No | No | Yes | No | Partial | Canada |
52 | f | A | 15 | AIDP | No | nr | Yes | No | Partial | Swiss |
63 | f | A | 7 | AIDP | nr | nr | Yes | No | Yes | Swiss |
61 | f | A | 22 | AIDP | No | nr | Yes | No | Partial | Swiss |
53 | f | B | nr | AIDP | No | No | PE | No | Partial | Turkey |
51 | f | A | 14 | MFS | nr | nr | Yes | No | Partial | Spain |
56 | f | A | 15 | AIDP | No | nr | Yes | Yes | Partial | Spain |
68 | m | A | 14 | AIDP | nr (ASPC) | nr | Yes, PE | Yes | Partial | Austria |
55 | f | A | 14 | AIDP | nr | No | Yes | Yes | Partial | Spain |
53 | m | A | 24 | AIDP | No | No | Yes | No | Yes | Netherlands |
57 | m | A | 6 | AIDP | No | AHT, psoriasis | Yes | Yes | Partial | UK |
21 | m | A | 16 | AIDP | nr | AHT, DM | PE | No | Yes | USA |
41 | m | A | 10 | AIDP | nr | DM | Yes | No | Partial | Iran |
38 | m | A | 16 | AIDP | nr | AHT | PE | No | Yes | Iran |
14 | f | A | nr | GBS | nr | No | Yes | No | Yes | Iran |
49 | m | A | 14 | AIDP | No | No | Yes | No | Yes | UK |
68 | m | A | 5 | AIDP | nr | AHT, HLP | Yes | No | Yes | Italy |
11 | m | A | 21 | AIDP | nr | No | Yes | No | Yes | Saudi |
15 | m | A | nr | AMAN | No | No | Yes | No | Partial | Brazil |
72 | m | A | 18 | AIDP | No | nr | Yes | Yes | Partial | Italy |
72 | m | A | 30 | AIDP | No | nr | Yes | Yes | Partial | Italy |
49 | f | A | 14 | AIDP | No | nr | Yes | No | Partial | Italy |
94 | m | A | 33 | AIDP | nr | nr | S | No | Partial | Italy |
76 | m | A | 22 | AIDP | No | nr | Yes | Yes | Partial | Italy |
64 | m | A | nr | GBS? | nr | DM | Yes | Yes | Yes | Japan |
77 | m | A | nr | AIDP | nr | AHT, HLP | Yes | No | Yes | Spain |
58 | f | A | 6 | AIDP | No | nr | PE | No | Yes | USA |
56 | f | A | 7 | AIDP | No | AHT, thyroxin ↓ | nr | nr | Partial | Germany |
61 | f | A | 14 | AMAN | No | AHT, HLP | PE | No | Yes | USA |
75 | m | A | nr | nr | No | spinal trauma | Yes | No | Yes | USA |
37 | nr | A | 10 | nr | nr | nr | nr | nr | nr | Belgium |
60 | f | A | 22 | nr | nr | Migraine | Yes | No | Partial | USA |
∅57 | 33 m | nr | 0–37 | nr | nr | nr | Yes, n = 46 | nr | Death, n = 1 | UK, n = 47 |
PE, n = 1 | nr, n = 46 | |||||||||
51 | m | A | 12 | AIDP | No | nr | Yes | Yes | Partial | Germany |
34 | m | A | 4 | PNC | nr | Strabism | Yes | No | Partial | USA |
71 | f | A | Days | PNC | nr | AHT | No | No | Partial | USA |
65 | m | A | 3 | AIDP | nr | No | Yes | No | Yes | Germany |
74 | f | A | nr | AIDP | No | Lymphoma | Yes | No | Yes | Spain |
49 | m | A | 14 | MFS | No | Crohn’s disease | Yes | Yes | partial | USA |
65 | f | A | nr | AIDP | nr | Fibromyalgia | Yes | Yes | Death | Italy |
12 | m | A | 7 | nr | nr | No | Yes | Yes | Death | Tanzania |
88 | f | A | 2 | AMSAN | nr | nr | PE | Yes | Partial | Iran |
47 | m | A | 7 | AMSAN | nr | nr | PE | Yes | Death | Iran |
58 | m | A | 9 | AMSAN | nr | nr | Yes, PE | Yes | Death | Iran |
54 | m | A | 3 | nr | nr | GBS, DN | Yes | No | Yes | USA |
57 | m | A | nr | AMAN | nr | nr | Yes | No | nr | Italy |
37 | m | A | 14 | AIDP | nr | nr | Yes | Yes | Partial | Iran |
41 | m | A | 10 | AIDP | No | nr | Yes | No | Yes | Guinea |
76 | m | A | 7 | AIDP | No | Cardiomyopathy | Yes | No | Partial | France |
∅59.2 | 22 m | A | 16–35 | AIDP, n = 23 | nr | Several | n = 25 | n = 5 | Partial | UK, n = 30 |
AMAN, n = 2 | PE, n = 2 | |||||||||
44 | m | A | nr | nr | nr | AHT, asthma | Yes | No | Yes | USA |
54 | f | A | 20 | AMAN | nr | Asthma | No | No | Partial | Japan |
55 | f | A | 11 | AMSAN | nr | Lung disease | Yes | Yes | Death | Iran |
8 | m | B | nr | AIDP | No | No | Yes | Yes | Partial | USA |
65 | m | A | 14 | AIDP | nr | nr | Yes | No | Partial | Iran |
70 | f | A | 90 | nr | nr | RSD | Yes | No | Yes | USA |
55 | f | A | 10 | AMAN | nr | DM, AHT | Yes | No | Partial | India |
72 | m | A | 6 | AIDP | nr | AHT | Yes | Yes | Death | India |
55 | m | A | 7 | AMSAN | nr | DM, AHT, RI | Yes | No | Partial | India |
49 | m | A | 10 | AIDP | nr | DM, AHT | Yes | No | Partial | India |
53 | m | A | nr | nr | nr | nr | Yes | No | Partial | Italy |
36 | m | A | 18 | AIDP | nr | AHT, NTX | Yes | Yes | Partial | USA |
57 | m | A | 17 | AIDP | nr | nr | Yes | No | Partial | Italy |
∅53 | 11 m | A | 0.5–28 | AIDP | No, n = 4 | nr | Yes, n = 15 | nr | Partial, | Italy, n = 17 |
PE, n = 2 | Death, n = 1 | |||||||||
54 | f | AB | 0 | nr | No | AHT | Yes | No | Partial | Spain |
58 | f | A | 14 | nr | nr | Disc prolapse | Yes | No | Partial | USA |
65 | m | A | nr | AIDP | nr | nr | Yes | No | Partial | Italy |
73 | m | AB | 0 | AIDP | No | nr | Yes | No | Partial | Italy |
55 | m | A | 20 | AIDP/MFS | No | nr | Yes | No | Partial | Italy |
46 | f | A | 3 | AIDP | No | nr | Yes | No | Partial | Italy |
60 | m | A | 20 | AMSAN | No | nr | Yes | No | Partial | Italy |
63 | f | A | 15 | AMSAN | nr | nr | Yes | No | Partial | Italy |
~ 35 | m | A | nr | AMAN | No | nr | Yes | No | Partial | UK |
49 | m | A | 11 | PCB | No | AHT, seminoma | No | No | Partial | Italy |
54 | m | A | 4 | AIDP | nr | AHT, obesity | Yes | Yes | Partial | Spain |
54 | nr | nr | nr | nr | No | AHT, HLP | Yes | Yes | Yes | Spain |
72 | f | A | 8 | AIDP | No | nr | Yes | Yes | Partial | Italy |
48 | m | A | 18 | AIDP | nr | DM | PE | No | Partial | USA |
46 | m | A | 18 | AIDP | nr | nr | No | No | Partial | Iran |
65 | m | A | 10 | AIDP | nr | nr | Yes | No | Partial | Iran |
66 | f | B | No symptom | AIDP | nr | nr | Yes | No | Partial | Italy |
66 | f | A | 30 | AIDP | nr | DM, AHT, arthritis | Yes | No | Partial | Iran |
55 | f | A | 31 | AMSAN | nr | COPD | Yes | Yes | Death | Iran |
14 | f | A | nr | nr | nr | No | Yes | No | Yes | Iran |
38 | m | A | 16 | AIDP | nr | No | PE | No | Partial | Iran |
20-63 | 7 m | nr | nr | AIDP | nr | nr | Yes | No | Partial | UK, n = 7 |
65 | m | A | 5 | AIDP | nr | DM, AHT | Yes | Yes | Death | Sudan |
43 | m | A | 10 | AIDP | nr | nr | Yes | No | Partial | Spain |
63 | m | A | 1 | MFS | nr | nr | No | No | Partial | UK |
61 | m | A | nr | MFS | No | nr | Yes | No | Yes | Germany |
58 | m | B | nr | AIDP | nr | nr | Yes | Yes | Partial | UK |
70 | f | A | 15 | AMAN | nr | AHTt, obesity | Yes, PE | No | Partial | Italy |